Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

A woman developed lupus after taking hydroxyurea for two years.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

The treatment was not recommended due to limited effectiveness and significant side effects.

Imiquimod may be a better non-surgical treatment for cervical pre-cancer, but its effectiveness for vaginal pre-cancer is unclear, and it has some side effects.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

Methotrexate plus prednisolone had the fewest serious side effects.

Imiquimod cream can rarely cause temporary hair loss.

A lotion with tretinoin, minoxidil, and betamethasone valerate helped treat a woman's skin infection.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Deucravacitinib may effectively treat discoid lupus erythematosus.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.